ProQR rises after IPO prices at top of range

By The Associated Press | Posted - Sep. 18, 2014 at 10:40 a.m.



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) — Shares of ProQR Therapeutics are surging after the Dutch drugmaker's expanded IPO priced at the top of its expected range.

ProQR's offering of 7.5 million shares priced at $13 per share. It had expected to sell 6.3 million shares for between $11 and $13 per share.

The company said Thursday it expects $88.4 million in proceeds after expenses and underwriting discounts.

The stock climbed $4.17, or 32 percent, to $17.17 in midday trading. The shares are trading on the Nasdaq Global Market under the ticker symbol "PRQR."

ProQR Therapeutics NV says it will use the funds from its IPO for clinical development of its lead product candidate, a therapy intended to treat cystic fibrosis, and for preclinical testing of a second drug.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast